SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001477932-18-003125
Filing Date
2018-06-19
Accepted
2018-06-19 17:24:53
Documents
72
Period of Report
2018-04-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q pvotf_10q.htm 10-Q 368197
2 CERTIFICATION pvotf_ex311.htm EX-31.1 7564
3 CERTIFICATION pvotf_ex312.htm EX-31.2 7520
4 CERTIFICATION pvotf_ex321.htm EX-32.1 3654
5 CERTIFICATION pvotf_ex322.htm EX-32.2 3652
  Complete submission text file 0001477932-18-003125.txt   2984994

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT pvotf-20180430.xml EX-101.INS 540411
7 XBRL TAXONOMY EXTENSION SCHEMA pvotf-20180430.xsd EX-101.SCH 56801
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE pvotf-20180430_cal.xml EX-101.CAL 45424
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE pvotf-20180430_def.xml EX-101.DEF 143423
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE pvotf-20180430_lab.xml EX-101.LAB 253263
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE pvotf-20180430_pre.xml EX-101.PRE 227103
Mailing Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6
Business Address 1275 WEST 6TH AVENUE VANCOUVER A1 V6H 1A6 604 805 7783
Pivot Pharmaceuticals Inc. (Filer) CIK: 0001464165 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0131
Type: 10-Q | Act: 34 | File No.: 333-161157 | Film No.: 18907993
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences